Bank of Montreal plans buffered bullish notes on Nasdaq Biotech fund

By Susanna Moon

Chicago, Nov. 6 – Bank of Montreal plans to price 0% buffered bullish enhanced return notes due Nov. 30, 2017 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to a 424B2 filed with the Securities and Exchange Commission.

The payout at maturity will be par plus 150% of any fund gain, up to a cap of $1,165 for each $1,000 principal amount.

Investors will receive par if the fund falls by up to 15% and will lose 1% for each 1% decline beyond 15%.

BMO Capital Markets Corp. is the agent.

The notes will price on Nov. 24 and settle on Nov. 30.

The Cusip number is 06366R4A0.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.